Sunshine Biopharma (OTCMKTS:SBFM) Stock In Focus After Announcing a Patent Application

October 7, 2021

Sunshine Biopharma (OTCMKTS:SBFM) has just filed a patent application for a potential new treatment for neurodegenerative disorders. It includes experimental results that show certain mRNA molecules provide protective effects against oxidative stress in differentiated neuronal cells. It is a process that mimics neuronal degeneration. Neurodegeneration happens when there is progressive loss of neuronal function – it could eventually result in cell death. Amyotrophic lateral sclerosis (ALS), Parkinson’s disease, multiple sclerosis,…

Read More >>

Sunshine Biopharma Inc. (OTCMKTS:SBFM) Stock Moves Up 33%: Here is Why

August 13, 2021

Sunshine Biopharma Inc. (OTCMKTS:SBFM) jumped 33% after announcing that it has mapped the mutations detected in the Delta variant and other variants of concern (“VOC”) recognized so far and that most of the mutations are found in the Spike protein, with just a few located in the genomic markers encoding nsp3, which is amulti-domain peptide that comprises the PLpro enzyme.  Surprisingly, no changes were found in the region that makes…

Read More >>